Perspectives on the Management of Oligometastatic Disease in Esophago-Gastric Cancer

por Goetze, Thorsten Oliver, Al-Batran, Salah-Eddin
Publicado 2022

Multimodal Treatment Strategies in Esophagogastric Junction Cancer: a Western Perspective

por Goetze, Thorsten Oliver, Al-Batran, Salah-Eddin, Berlth, Felix, Hoelscher, Arnulf Heinrich
Publicado 2019

Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma

por Werner, Dominique, Atmaca, Akin, Pauligk, Claudia, Pustowka, Anette, Jäger, Elke, Al-Batran, Salah-Eddin
Publicado 2013

Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review

por Chiorean, Elena Gabriela, Cheung, Winson Y., Giordano, Guido, Kim, George, Al-Batran, Salah-Eddin
Publicado 2019

Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal...

por Lordick, Florian, Al-Batran, Salah-Eddin, Ganguli, Arijit, Morlock, Robert, Sahin, Ugur, Türeci, Özlem
Publicado 2021

The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer

por Atmaca, Akin, Werner, Dominique, Pauligk, Claudia, Steinmetz, Kristina, Wirtz, Ralph, Altmannsberger, Hans-Michael, Jäger, Elke, Al-Batran, Salah-Eddin
Publicado 2012

The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing

por Werner, Dominique, Battmann, Achim, Steinmetz, Kristina, Jones, Tobin, Lamb, Tiffany, Martinez, Michele, Altmannsberger, Hans-Michael, Al-Batran, Salah-Eddin
Publicado 2014

SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer

por Atmaca, Akin, Wirtz, Ralph W, Werner, Dominique, Steinmetz, Kristina, Claas, Silke, Brueckl, Wolfgang M, Jäger, Elke, Al-Batran, Salah-Eddin
Publicado 2015

Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

por Al‐Batran, Salah‐Eddin, Moorahrend, Enno, Maintz, Christoph, Goetze, Thorsten O., Hempel, Dirk, Thuss‐Patience, Peter, Gaillard, Vincent E., Hegewisch‐Becker, Susanna
Publicado 2020

RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomi...

por Lorenzen, Sylvie, Biederstädt, Alexander, Ronellenfitsch, Ulrich, Reißfelder, Christoph, Mönig, Stefan, Wenz, Frederik, Pauligk, Claudia, Walker, Martin, Al-Batran, Salah-Eddin, Haller, Bernhard, Hofheinz, Ralf-Dieter
Publicado 2020

Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in...

por Goetze, Thorsten O., Bechstein, Wolf O., Bankstahl, Ulli Simone, Keck, Tobias, Königsrainer, Alfred, Lang, Sven A., Pauligk, Claudia, Piso, Pompiliu, Vogel, Arndt, Al-Batran, Salah-Eddin
Publicado 2020

VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a compara...

por Thomaidis, Thomas, Maderer, Annett, Al-Batran, Salah-Eddin, Kany, Janis, Pauligk, Claudia, Steinmetz, Kristina, Schad, Arno, Hofheinz, Ralf, Schmalenberg, Harald, Homann, Nils, Galle, Peter Robert, Moehler, Markus
Publicado 2014

AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxi...

por Kripp, Melanie, Prasnikar, Nicole, Vehling-Kaiser, Ursula, Quidde, Julia, Al-Batran, Salah-Eddin, Stein, Alexander, Neben, Kai, Hannig, Carla Verena, Tessen, Hans Werner, Trarbach, Tanja, Hinke, Axel, Hofheinz, Ralf-Dieter
Publicado 2017

Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma

por Koch, Christine, Reitz, Cornelius, Schreckenbach, Teresa, Eichler, Katrin, Filmann, Natalie, Al-Batran, Salah-Eddin, Götze, Thorsten, Zeuzem, Stefan, Bechstein, Wolf Otto, Kraus, Thomas, Bojunga, Jörg, Düx, Markus, Trojan, Jörg, Blumenstein, Irina
Publicado 2019

Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer

por Knödler, Maren, Körfer, Justus, Kunzmann, Volker, Trojan, Jörg, Daum, Severin, Schenk, Michael, Kullmann, Frank, Schroll, Sebastian, Behringer, Dirk, Stahl, Michael, Al-Batran, Salah-Eddin, Hacker, Ulrich, Ibach, Stefan, Lindhofer, Horst, Lordick, Florian
Publicado 2018

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritone...

por Oliver Goetze, Thorsten, Al-Batran, Salah-Eddin, Pabst, Urs, Reymond, Marc, Tempfer, Clemens, Bechstein, Wolf O., Bankstahl, Ulli, Gockel, Ines, Königsrainer, Alfred, Kraus, Thomas, Mönig, Stefan P., Rau, Beate, Schwarzbach, Matthias, Piso, Pompiliu
Publicado 2018

Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase I...

por Götze, Thorsten O., Piso, Pompiliu, Lorenzen, Sylvie, Bankstahl, Ulli S., Pauligk, Claudia, Elshafei, Moustafa, Amato, Giuseppe, Reim, Daniel, Bechstein, Wolf O., Königsrainer, Alfred, Mönig, Stefan P., Rau, Beate, Schwarzbach, Matthias, Al-Batran, Salah-Eddin
Publicado 2021

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

por von Minckwitz, Gunter, Harder, Sebastian, Hövelmann, Sascha, Jäger, Elke, Al-Batran, Salah-Eddin, Loibl, Sibylle, Atmaca, Akin, Cimpoiasu, Christian, Neumann, Antje, Abera, Aklil, Knuth, Alexander, Kaufmann, Manfred, Jäger, Dirk, Maurer, Alexander B, Wels, Winfried S
Publicado 2005

Correction: Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

por von Minckwitz, Gunter, Harder, Sebastian, Hövelmann, Sascha, Jäger, Elke, Al-Batran, Salah-Eddin, Loibl, Sibylle, Atmaca, Akin, Cimpoiasu, Christian, Neumann, Antje, Abera, Aklil, Knuth, Alexander, Kaufmann, Manfred, Jäger, Dirk, Maurer, Alexander B, Wels, Winfried S
Publicado 2006

Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctio...

por Lorenzen, Sylvie, Schwarz, Alix, Pauligk, Claudia, Goekkurt, Eray, Stocker, Gertraud, Knorrenschild, Jorge Riera, Illerhaus, Gerald, Dechow, Tobias, Moehler, Markus, Moulin, Jean-Charles, Pink, Daniel, Stahl, Michael, Schaaf, Marina, Goetze, Thorsten Oliver, Al-Batran, Salah-Eddin
Publicado 2023